Companies thrive on performance, not news flow. Because, as shown here, news flow can be fabricated, and fabricated news flow does not attract professional investors. Doll didn't leave because he knew. He left because he is Sorensen's henchman, and Sorensen was no longer Chairman.
MY POSTS ARE OPINIONS ONLY, NOT FACTS OR ADVICE

Those companies are defunct and need to restart

How can there be any drive in a company that has no employees?

Hedge fund is driving it up for reverse split
The problem with this kind of artificial demand creation is that it will come back down to equilibrium sooner or later

aint none here

You are absolutely right. Have you noticed that "the third leg" doesn't post anymore? Very telling, and speaks for itself....

Things are not according to plan, however, A 1000:1 RS now doesn't hit $5 for uplist.

SEC likely to sniff around here

The news, when it comes, will involve substantial dilution, perhaps more than 80% of the company (to hedge fund, acquisition shares, convertible debt conversion, board and management if they ever hired any) and that is the likely reason for the tremendous drop. It may go down further first....

Big cram down will come with merger

Here is the math:

1.2B shares + $700K debt conversion at $0.005 = 1.34B shares

1000:1 RS = 1.34M shares at $6 meaning enterprise value pre merger is about $8M

But 25% for merger adds another 330,000 shares or a total of 1.67M or $8M valuation

Now give 20% option grants to new board, so $2M shares at $6, but that dilutes it down to $5 when shareholders see this

Hedge fund puts in $25M and owns 2/3 of company, 7M shares trading at $5 after RS and merger

Value depends entirely on whether they can revive the defunct NovaRx company can get a new Phase 3. Value goes up if they can and to pennies if they can't.

House of cards. Make 5X or lose it all.

sorry i am new in penny world and not sure I want to be here yet

don't have any other nicks, and not allen, don't know who that is

Correct. Vpro today appears to be an empty public shell with no revenue, no drugs and no tech. It appears that the current part time management is trying to inflate the stock with resumes and then stuff the company with deals that didn't go public on their own. No deals apparently done yet. A nonbinding letter of intent is not a deal. The financing has to come from somewhere and that means dilution. If they pull this off, Vpro may grow but might go down sharply along the way before going up a lot as these details become transparent, if they ever do. I am not a believer that a fat cat's prolific self authored resume substitutes for having a product on hand.

$5.00 = $5B

Where's the beef?

It's not Royston, it's science

Where is it? Show me without placating

Show me the money
The numbers and the science to justify, not the resumes

ViroPro, your BOD is no Lebron James....they are mediocrity with window dressing. No, just posting dressed up resumes of people who do not really work full time at the company does not guarantee anything. Where's the science? It doesn't exist unless they buy it. That will be highly dilutuive, resume of BOD or not.

The value is not a penny and a half. It is trading at an enterprise value of $15M -- over valued without science. If you are a trader, you know the stock price means nothing without considering the cap table. NovaRX has not yet been acquired, and when and if it is, it must be funded, With what? Hot air? Even if the so called Lebron James board has money, they will expect equity for it. That dilutes you

I am in when it drops to $2M, I short at $20M unless it has acquired the science....acquired, not LOI

Can't trip b/c I don't hold stock (or puts). Yet. I see what's about to happen also -- just not convinced this method of "financial engineering" won't fall on its own sword. VPRO needs substantive products first, science, not resumes or hedge fund managers. If it can acquire enough science without diluting the daylights out of itself, then the financial engineering might work, but a small hedge fund manager cannot make a $B company out of vapor.

Years ago. I am not a stock trader. I own significant stakes and have director and operating roles in multiple biotechs. You assume I want to short. I don't. under the right circumstances I would buy a stake to hold, but the price is too high right now

Rather presumptive. I work in the industry and have known this company and most of its principals for a long time

Not interested in bashing. Interested in the truth. I have no other names on iHub.

I do not know who Mr Green is....

My purpose is not to downgrade, and even if it was, I don't have the power to do so. Neither does anyone else on this board unless they do it with their money and not their words.

Maybe I was considering doing "real" business with VPRO and learned here why I should not.

Or maybe I am an SEC whistle blower.

Or maybe I am a lawyer collecting evidence. Ha.

Or maybe I am amused at what some people call doing business.

Or maybe I am just the boogie man.

Regardless, I know who some of you are and I know some of you use more than one handle and talk to yourselves like its a real conversation. Amusing!

You are wasting your time speculating! Go buy some more then, at more than VPRO is worth

IMHO, buy in much lower

Here is why. VPRO has only one asset - NovaRX. And actually they don't have it yet, they just have a nonbinding LOI. NovaRX has been around a while and has failed trials. Its value may be $10M at best on the junk yard sale. But since VPRO doesn't yet own it, you must discount it to say $5M. But wait a minute, NovaRX is not going through with this unless VPRO provides money which they don't have yet, so there is another dilution, let's value it at $2.5M, which is about 0.0025. Give them $100K for the value of the shell, so VPRO worth $2.6M. Let's buy in low at $0.002 and hope that past litigation does not bite them in A

its already ridiculously inflated

This is all rather weak IMHO.

A company with limited funding and progress (NovaRX) agrees to be bought out by a worthless penny stock and investors are supposed to gamble on this because of the resumes of the board??????? Wow!

First of all, its misguided to think that a board alone can overcome the weaknesses of an operating company. It cannot. The operating company has to have substance first.

Secondly, the valuable companies are going for traditional IPOs and not backing into empty shells with a history of litigation and loss of assets.

I can't wait for the price to go up so I can short it!!!!!!!!!!!!!!